116. V. R. Mudalir and V. Joshi ; Ind. J. Of Chem., 1995, 34(B), 456.117. Kammei, Hideo, Koide, Tatsurou ; Hashimato Yoko, Kojima, Takashi, Hasegawa,Makoto ; Chem. Abstr., 1997, 126, 258666v.118. De Vincenzo R., Seambla G. Panici, P. Benedess, Remelletti F. O.; Anticancerdrug. Res., 10(6), 481-90 (1995) ; Chem. Abstr., 1996, 124, 247r.119. Han, Rui, guo, Zong., Ru.; Chem. Abstr., 1998, 128, 110862b.120. Okuyama Torn ; Okada Yoshihito, Shibato Shoji et al. ; Chem. Abstr., 2000, 132,22752t.121. A. Tsotitns, K. Theodara et al.; PCT Int. Appl. WO. 99, 1999, 54, 278 ; Chem.Abstr., 1999, 131, 28260e.122. P. N. Sarma, B. Sreenivasulu ; J. Indian Chem. Soc., 1997 ; Chem. Abstr., 1998,128, 88799n.123. Liu, Mei, Wilairat Prapon, GO Mei-Lin ; J. Med. Chem., 2002, 45(8), 1735 ; Chem.Abstr., 2003, 139, 94746.124. Opletalova Veronika, L. Jahodar, D. Jun, L. Opletal ; Ceska a SlovenskaFarmacie., 2003, 52(1), 12-19 ; Chem. Abstr., 2003, 138, 265043.125. Rojas. Javier, J. N. Dominguez, J. E. Charris, Lobo Gricela, M. Paya, M. L.Ferrandiz ; Eur. J. med. Chem., 37(8),699-705 (2002) ; Chem. Abstr., 2003, 138,122472.126. Rojas. Javier, M. Paya, J. N. Qominguez, F. M. Luisa ; Bioorg. & Med. Chem.,Letters, 2002, 12(15), 1951-54 ; Chem. Abstr., 2003, 138, 39068.127. N. N. Mateeva, R. N. Kode, K. K. Redda ; J. Heterocycl. Chem., 2002, 39(6), 1251-58 ; Chem. Abstr., 2003, 138, 401568.128. Wu Jiu-Hong, Wang Xi- Hong, Yi Yang-Huy, Lee Kuo-Hsiung ; Bioorg. & Med.Chem. Jeff., 2003, 13(10), 1813-1815 ; Chem. Abstr., 2003, 139, 146483.129. G. A. Potter, P. C. Butter ; PCT Int., Appl. WO 03 2002, 028713 ( C1. A61K03100),Chem. Abstr., 2003, 138, 297623.130. G. A. Potter, Ijaz Taeeba ; Chem. Abstr., 2003, 138, 304053.131. C. Q. Meng and X. S. Zheng ; Zheng ; Bioorg Med. Chem. Lett. 2004, 14(6), 1513-1517.132. S. Khatib, O. Nerya, R. Musa, M. Shmuel, S. Tamir, J. Vaya ; Bioorg. Med. Chem.2005, 13(2), 443-41.168References…..
133. HH Ko, HK Hsieh, CT Liu, HC Lin, CM Teng, CN Lin ; J. Pharm. Pharmacol. 2004,56(10), 1333-7.134. Ziegler HL, Hansen HS, Staerk D, Christensen SB, Hagerstrand H, JaroszewskiJW ; Antimicrob Agents Chemother. 2004, 48(10), 4067-71.135. ML Go, M. Liu, P. Wilairat, PJ Rosenthal, KJ Saliba, K. Kirk ; Antimicrob AgentsChemother. 2004, 48(9), 3241-5.136. CX Xue, SY Cui, MC Liu, ZD Hu, BT Fan ; Eur. J. Med. Chem. 2004, 39(9), 745-53.137. Y. Fu, TC Hsieh, J. Guo, J. Kunicki, MY Lee, Z. Darzynkiewicz ; Biochem BiophysRes Commun. 2004, 332(1), 263-70.138. MJ Alcaraz, AM Vicente, A. Araico, JN Dominguez, MC Terencio, ML Ferrandiz ; Br.J. Pharmacol. 2004, 142(7), 1191-9.139. O. Nerya, R. Musa, S. Khatib, S. Tamir, J. Vaya ; Phytochemistry. 2004, 65(10),1389-95.140. Sabzevari O, Galati G, Moridani MY, Siraki A, O’ Brien PJ.; Chem Bio Interact.2004, 148(1-2), 57-67.141. HS Ban, K. Suzuki, SS Lim, SH Jung, S. Lee, J. Ji, HS Lee, YS Lee, KH Shin, K.Ohuchi ; Biochem Pharmacol. 67(8),2004, 1549-57.142. F. Hollosy, G. Keri, Curr Med Chem Anti-Can Agents. 4(2), 2004, 173-97.143. Mc Gavack, T.H.J. Chevalley, S. Keni-gsberg, and S. Pearsib; Bull N. Y. Med.Coll.,1953, 16 , 58143-a V. M. Parikh ; “Absorption spectroscopy of organic molecule” addition Wesleypub. Co. London, 1978, 243-258.143-b C. N. R. Rao ; “Chemical application of Infrared spectroscopy” Acadamiapress, New York, 1963.143-c A. R. Kartizky and R. Alan jones :; J. Chem. Soc., 1960, 2942.143-d Silerstein Dasler and Mosil ; “Spectroscopy identification of organiccompounds”, 1980.144. Miller, Lykos and Schmeising, J. Am. Chem. Soc., 1962, 84, 4623.145. I. J. Rinkes; Recl. Trav. Cairn Pays-Bas.,1927, 46268.146. G.A. Howard, B. Lythgoe and A.R. Todd; J. Chem. Soc., 1944,476.147. C.W. Whitehead and J.J. Traversol; J. Am. Chem. Soc., 1958, 80, 2185.148. H. Bredereck, F. Effenberger And H.J. Treiber; Chem. Ber., 1963, 96, 1505.149. D. J. Brown; Chem. Heterocyc. Compd., 1970, 20, 16-51.169References…..
- Page 3:
The Sarvodaya Education Society’s
- Page 6 and 7:
selfless help, moral support and gu
- Page 9 and 10:
Introduction and Spectral studies .
- Page 11 and 12:
“STUDIES ON SOME HETEROCYCLICENTI
- Page 13 and 14:
Pyrimidine derivatives have been pr
- Page 15 and 16:
Isoxazole derivative synthesized by
- Page 17 and 18:
“STUDIES ON SOMEHETEROCYCLIC ENTI
- Page 19 and 20:
(b) Pharmacokinetics: It is derived
- Page 21 and 22:
(C) Drug DevelopmentMany natural pr
- Page 23 and 24:
The process of drug design is exten
- Page 25 and 26:
(l) Non steroidal anti-inflammatory
- Page 27 and 28:
INTRODUCTIONThe aza-indolizine cont
- Page 29 and 30:
PHARMACEUTICAL IMPORTANTMuch resear
- Page 31 and 32:
Compd. R 1 R 2 R 3a :- H 7-Me-6,8-B
- Page 33 and 34:
S. Kristjan, Gudmundsson and A. Bra
- Page 35 and 36:
STUDIES ON IMIDAZOPYRIDINE DERIVATI
- Page 37 and 38:
(a) Chalcones with monoethanolamine
- Page 39 and 40:
Das B.P. et al. 111 have found that
- Page 41 and 42:
Furthermore, Alcaraz M.J, et al. 13
- Page 43 and 44:
REACTION SCHEMECl+ClOClOClClCH 3NH
- Page 45 and 46:
Instrument : SHIMADZU FTIR 8400 Spe
- Page 47 and 48:
SignalNo.SignalPosition(δppm)Relat
- Page 49 and 50:
ANTIMICROBIAL ACTIVITYProducts : Ch
- Page 51 and 52:
The reaction mixture was poured on
- Page 53 and 54:
TABLE NO.- 1A BIOLOGICAL SCREENING
- Page 55 and 56:
PART-IISTUDIES ON PYRIMIDINES
- Page 57 and 58:
The self consistent (pi)electron de
- Page 59 and 60:
class of dye viz. trichloro pyrimid
- Page 61 and 62:
ability to cleave nucleic acid targ
- Page 63 and 64:
SSNHNHoONOoONOo(11) (12)oOHThe Pyri
- Page 65 and 66:
called ABPP or bropirimine(2-amino-
- Page 67 and 68:
acid so that it could be utilized f
- Page 69 and 70:
have reported the 5-substitutedfuro
- Page 71 and 72:
maturation of the viral mRNA molecu
- Page 73 and 74:
Nevertheless, these compounds const
- Page 75 and 76:
OHHNCH 3Cl(CH 2 )nSNNR 2R 1N H 2NSR
- Page 77 and 78:
SECTION-ISTUDIES ONOXOPYRIMIDINES
- Page 79 and 80:
PHARMACEUTICAL IMPORTANCEIn recent
- Page 81 and 82:
REACTION SCHEMECH 3NNCHOCl10% KOH R
- Page 83 and 84:
INSTRUMENT :SHIMADZU FTIR 8400 Spec
- Page 85 and 86:
SignalNo.SignalPosition(δppm)Relat
- Page 87 and 88:
EXPERIMENTALSynthesis and therapeut
- Page 89 and 90:
TABLE NO.- 2(IB)PHYSICAL CONSTANTS
- Page 91 and 92:
INTRODUCTIONThiopyrimidine derivati
- Page 93 and 94:
H 3 COHNRH 3 CH 3 CNHS( IV ) R = ar
- Page 95 and 96:
SYNTHESIS AND THERAPEUTIC EVALUATIO
- Page 97 and 98:
IR SPECTRAL STUDIES OF 6-(2-(4-CHLO
- Page 99 and 100:
NMR SPECTRAL STUDIES OF 6-(2-(4-CHL
- Page 101 and 102:
MASS SPECTRAL STUDIES OF 6-(2-(4-CH
- Page 103 and 104:
[F] Antimicrobial activity of 6-(2-
- Page 105 and 106:
SECTION-IIISTUDIES ONAMINOPYRIMIDIN
- Page 107 and 108:
ArCHO+ArCOCH3NaOHMethanolR R 1ONaOH
- Page 109 and 110:
SYNTHESIS AND THERAPEUTIC EVALUATIO
- Page 111 and 112:
IR SPECTRAL STUDIES OF 4-(2-(4-CHLO
- Page 113 and 114:
NMR SPECTRAL STUDIES OF 4-(2-(4-CHL
- Page 115 and 116:
MASS SPECTRAL STUDIES OF 4-(2-(4-CH
- Page 117 and 118:
[F] Antimicrobial activity of 4-(2-
- Page 119 and 120:
PART-IIISTUDIES ONCYCLOHEXENONES
- Page 121 and 122:
2. Michael addition of chalcone wit
- Page 123 and 124:
Rheinheimer J. et al. 381have synth
- Page 125 and 126:
SYNTHESIS AND THERAPEUTIC EVALUATIO
- Page 127 and 128:
IR SPECTRAL STUDIES OF ETHYL-6-(2-(
- Page 129 and 130:
NMR SPECTRAL STUDIES OF ETHYL-6-(2-
- Page 131 and 132:
MASS SPECTRAL STUDIES OF ETHYL-6-(2
- Page 133 and 134:
Antimicrobial testing was carried o
- Page 135 and 136:
PART-IVSTUDIES ON PYRAZOLINES
- Page 137 and 138:
H 2 C= CHCN + Ar - NHNH 2NArN(3) 2
- Page 139 and 140: PHARMACEUTICAL IMPORTANCE :2- Pyraz
- Page 141 and 142: Kadu et al. 424 and antimicrobial b
- Page 143 and 144: REACTION SCHEMECH 3NNClCHO10% KOHRO
- Page 145 and 146: Instrument : SHIMADZU FTIR 8400 Spe
- Page 147 and 148: SignalNo.SignalPosition(δppm)Relat
- Page 149 and 150: EXPERIMENTALSynthesis and therapeut
- Page 151 and 152: TABLE NO.- 4(B)PHYSICAL CONSTANTS O
- Page 153 and 154: INTRODUCTION:Isoxazole come under t
- Page 155 and 156: PHARMACEUTICAL IMPORTANCE :Isoxazol
- Page 157 and 158: SYNTHESISAND THERAPEUTIC EVALUATION
- Page 159 and 160: IR SPECTRAL STUDIES OF 2-(4-CHLOROP
- Page 161 and 162: NMR SPECTRAL STUDIES OF 2-(4-CHLORO
- Page 163 and 164: MASS SPECTRAL STUDIES OF 2-(4-CHLOR
- Page 165 and 166: [F]Antimicrobial activity of 2-(4-c
- Page 167 and 168: PART-VISTUDIES ON OXIRANES
- Page 169 and 170: ( iii ) Epoxidation can also been c
- Page 171 and 172: Moreover, Nomura Yutaka et al. 487
- Page 173 and 174: SYNTHESIS AND THERAPEUTIC EVALUATIO
- Page 175 and 176: IR SPECTRAL STUDIES OF (3-(2-(4-CHL
- Page 177 and 178: NMR SPECTRAL STUDIES OF (3-(2-(4-CH
- Page 179 and 180: MASS SPECTRAL STUDIES OF (3-(2-(4-C
- Page 181 and 182: [F] Antimicrobial activity of (3-(2
- Page 184 and 185: 1. J. A. Joule and K. Mills; Hetero
- Page 186 and 187: 37. James J. Kaminski, D. G. perkin
- Page 188 and 189: 78. Ms. B. S. Hastak and B. J. Ghiy
- Page 192 and 193: 150. S. Inoue, A. J. Saggimoto and
- Page 194 and 195: 197. S. S. Bahekar, D. B. Shinde; A
- Page 196 and 197: 238. A. Kreutzberger and M. Sellhei
- Page 198 and 199: 280. See, for example, W. H. Prusof
- Page 200 and 201: 326. C. W. Whitehead and J. J. Trav
- Page 202 and 203: 366. Nagarjan K., Shenoy S. J.; Ind
- Page 204 and 205: 396. Ausra Voskiene,Vytautas Mickev
- Page 206 and 207: 432. Solankee Sejal; Prajapati Yoge
- Page 208 and 209: 463. Mishra Ashutosh ; Jain Sanmati
- Page 210 and 211: 496. Kaneko Mashami, Saitoh Yutaka,
- Page 212 and 213: CH 3CH 3NNClNNClORHNONRRRC 6 H 5 -
- Page 214 and 215: CH 3CH 3NNClNNClEtOOCORHNNRRRC 6 H